Physicians' attitudes about multiplex tumor genomic testing.

ABSTRACT:

Purpose

Although predictive multiplex somatic genomic tests hold the potential to transform care by identifying targetable alterations in multiple cancer genes, little is known about how physicians will use such tests in practice.

Participants and methods

Before the initiation of enterprise-wide multiplex testing at a major cancer center, we surveyed all clinically active adult cancer physicians to assess their current use of somatic testing, their attitudes about multiplex testing, and their genomic confidence.

Results

A total of 160 physicians participated (response rate, 61%): 57% were medical oncologists; 29%, surgeons; 14% radiation oncologists; 37%, women; and 83%, research principal investigators. Twenty-two percent of physicians reported low confidence in thei

SUBMITTER: Gray SW 

PROVIDER: S-EPMC3992721 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature